Citations

Institution: Mayo Clinic Clear

Showing 10 of 108152 citations.

Outcomes of Complete Versus Partial Surgical Stabilization of Flail Chest
Nickerson, Terry P., Thiels, Cornelius A. , Kim, Brian D. , Zielinski, Martin D. , Jenkins, Donald H. , Schiller, Henry J., Thiels, Cornelius A

World Journal of Surgery | September 15, 2015 | Volume: 40 | Issue: 1 | Pages: 236-241

10.1007/s00268-015-3169-3 | PMID 26374224 Get It

AbstractBackgroundRib fractures are common after chest wall trauma. For patients with flail chest, surgical stabilization is a promising technique for reducing morbidity. Anatomical difficulties often lead to an inability to completely repair the flail chest; thus, the result is partial flail chest stabilization (PFS). We hypothesized that patients with PFS have outcomes similar to those undergoing complete flail chest stabilization (CFS).MethodsA prospectively collected database of all patients who underwent rib fracture stabilization procedures from August 2009 until February 2013 was reviewed. Abstracted data included procedural and complication data, extent of stabilization, and pulmonary function test results.ResultsOf 43 patients who underwent operative stabilization of flail chest, 23 (53 %) had CFS and 20 (47 %) underwent PFS. Anterior location of the fracture was the most common reason for PFS (45 %). Age, sex, operative time, pneumonia, intensive care unit and hospital length of stay, and narcotic use were the same in both groups. Total lung capacity was significantly improved in the CFS group at 3 months. No chest wall deformity was appreciated on follow‐up, and no patients underwent additional stabilization procedures following PFS.ConclusionDespite advances in surgical technique, not all fractures are amenable to repair. There was no difference in chest wall deformity, narcotic use, or clinically significant impairment in pulmonary function tests among patients who underwent PFS compared with CFS. Our data suggest that PFS is an acceptable strategy and that extending or creating additional incisions for CFS is unnecessary.
Reply: Further Progress in Understanding Fibrosing Mediastinitis
Peikert, Tobias, Westerly, Blair, Specks, Ulrich

American Journal of Respiratory and Critical Care Medicine | September 15, 2015 | Volume: 192 | Issue: 6 | Pages: 768-768

10.1164/rccm.201506-1183le | PMID 26371818 Get It

Sexual health in hematopoietic stem cell transplant recipients
Li, Zhuoyan , Mewawalla, Prerna , Yong, Agnes S. M. , Shaw, Bronwen E. , Hashmi, Shahrukh K. , Jagasia, Madan , Mohty, Mohamad , Majhail, Navneet S. , Hashmi, Shahrukh, Stratton, Pamela , Savani, Bipin N. , Rovó, Alicia , Majhail, Navneet S , Mohty, Mohamad

Cancer | September 15, 2015 | Volume: 121 | Issue: 23 | Pages: 4124-4131

10.1002/cncr.29675 | PMID 26372459 Get It

Hematopoietic stem cell transplantation (HSCT) plays a central role in patients with malignant and, increasingly, nonmalignant conditions. As the number of transplants increases and the survival rate improves, long‐term complications are important to recognize and treat to maintain quality of life. Sexual dysfunction is a commonly described but relatively often underestimated complication after HSCT. Conditioning regimens, generalized or genital graft‐versus‐host disease, medications, and cardiovascular complications as well as psychosocial problems are known to contribute significantly to physical and psychological sexual dysfunction. Moreover, it is often a difficult topic for patients, their significant others, and health care providers to discuss. Early recognition and management of sexual dysfunction after HSCT can lead to improved quality of life and outcomes for patients and their partners. This review focuses on the risk factors for and treatment of sexual dysfunction after transplantation and provides guidance concerning how to approach and manage a patient with sexual dysfunction after HSCT. Cancer 2015;121:4124–4131. © 2015 American Cancer Society.
ICSH recommendations for assessing automated high‐performance liquid chromatography and capillary electrophoresis equipment for the quantitation of HbA 2
Stephens, A. D., Colah, Roshan , Fucharoen, Suthat , HOYER, J. D., Keren, David F. , McFarlane, Andrew, Wild, Barbara , Perrett, David Ian

International Journal of Laboratory Hematology | September 15, 2015 | Volume: 37 | Issue: 5 | Pages: 577-582

10.1111/ijlh.12413 | PMID 26372049 Get It

Summary Automated high performance liquid chromatography and Capillary electrophoresis are used to quantitate the proportion of Hemoglobin A 2 (HbA 2 ) in blood samples order to enable screening and diagnosis of carriers of β‐thalassemia. Since there is only a very small difference in HbA 2 levels between people who are carriers and people who are not carriers such analyses need to be both precise and accurate. This paper examines the different parameters of such equipment and discusses how they should be assessed.
The heparan sulfate mimetic PG545 interferes with Wnt/β-catenin signaling and significantly suppresses pancreatic tumorigenesis alone and in combination with gemcitabine
Jung, Deok‐Beom , Yun, Miyong , Kim, Eun-Ok , Kim, Bonglee , Wang, Enfeng , Hammond, Edward , Dredge, Keith , Shridhar, Viji , Kim, Sung‐Hoon , Kim, Jaekwang , Jung, Ji Hoon , Mukhopadhyay, Debabrata

Oncotarget | September 15, 2015 | Volume: 6 | Issue: 7 | Pages: 4992-5004

10.18632/oncotarget.3214 | PMID 25669977 Get It

Deficiency of AMPK in CD8+ T cells suppresses their anti-tumor function by inducing protein phosphatase-mediated cell death
Rao, Enyu , Zhu, Ganqian , Hao, Jiaqing , Persson, Xuan-Mai T., Egilmez, Nejat K. , Suttles, Jill, Li, Bing , Zhang, Yuwen

Oncotarget | September 15, 2015 | Volume: 6 | Issue: 10 | Pages: 7944-7958

10.18632/oncotarget.3501 | PMID 25760243 Get It

Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma
Demosthenous, Christos , Stenson, Mary, Wellik, Linda, Link, Brian K. , Hege, Kristen , Sotomayor, Eduardo M. , Han, Jing-Jing, Stenson, Mary J, Wellik, Linda E, Han, Jing , Maurer, Matthew J. , Doǧan, Ahmet , Witzig, Thomas E. , Gupta, Mamta , Link, Brian K

Oncotarget | September 15, 2015 | Volume: 6 | Issue: 11 | Pages: 9488-9501

10.18632/oncotarget.3378 | PMID 25839159 Get It

Overexpression of mutantPtchin rhabdomyosarcomas is associated with promoter hypomethylation and increased Gli1 and H3K4me3 occupancy
Nitzki, Frauke, Tolosa, Ezequiel J. , Cuvelier, Nicole, Frommhold, Anke, Salinas-Riester, Gabriela, Fernández-Zapico, Martín E. , Hahn, Heidi , Johnsen, Steven A.

Oncotarget | September 15, 2015 | Volume: 6 | Issue: 11 | Pages: 9113-9124

10.18632/oncotarget.3272 | PMID 25823816 Get It

Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer
Zhang, Yaqin , Mehta, Amit, Boufraqech, Myriem , Tian, Ze , Yu, Zhiya , Boxer, Matthew B., Kiefer, Jeffrey , Copland, John A. , Smallridge, Robert C., Li, Zhuyin, Kebebew, Electron , Zhang, Lisa M. , Davis, Sean , Wang, Jing , Shen, Min

Oncotarget | September 15, 2015 | Volume: 6 | Issue: 11 | Pages: 9073-9085

10.18632/oncotarget.3268 | PMID 25940539 Get It